Adhesion of uric acid crystals to the surface of renal epithelial cells

American Journal of Physiology - Renal Physiology

Volumn 278, Issue 6 47-6, 2000, Pages

  Koka, Rima M ^a   Huang, Erick ^a   Lieske, John C ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b MAYO CLINIC   (United States)

Author keywords

3T3 fibroblasts; BSC 1 cells; Glycosaminoglycans; Madin Darby canine kidney cells; Nephrolithiasis

Indexed keywords

URIC ACID;

ANIMAL CELL; ARTICLE; CELL ADHESION; DISEASE ASSOCIATION; HYDROGEN BOND; HYDROPHOBICITY; KIDNEY TUBULE CELL; MONKEY; NEPHROLITHIASIS; NONHUMAN; PRIORITY JOURNAL; STONE FORMATION; URIC ACID STONE;

EID: 0033917258     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.2000.278.6.f989     Document Type: Article

References (38)

1. Burns JR and Finlayson B. A proposal for a standard reference artificial urine in in vitro urolithiasis experiments. Invest Urol 18: 167-169, 1980.
2. Burt HM and Jackson JK. Role of membrane proteins in monosodium urate crystal-membrane interactions. II. Effect of pretreatments with membrane permeable and impermeable protein crosslinking agents. J Rheumatol 17: 1359-1363, 1990.
3. Burt HM, Jackson JK, and Kim KJK. Role of membrane proteins in monosodium urate crystal-membrane interactions. I. Effect of pretreatment of erythrocyte membranes with glutaraldehyde and neuraminidase. J Rheumatol 17: 1353-1358, 1990.
4. Cheung HS, Sallis JD, Mitchell PG, and Struve JA. Inhibition of basic calcium phosphate crystal-induced mitogenesis by phosphocitrate. Biochem Biophys Res Commun 171: 20-25, 1990.
5. Coe FL. Uric acid and calcium oxalate nephrolithiasis. Kidney Int 24: 392-403, 1983.
6. De Bruijn WC, Boevé ER, van Run PRWA, Van Miert PPMC, de Water R, Romijn JC, Verkoelen CF, Cao LC, van't Noordende JM, and Schröder FH. Etiology of calcium oxalate nephrolithiasis in rats. II. The role of the papilla in stone formation. Scanning Microsc 9: 115-125, 1995.
7. Emmerson BT, Cross M, Osborne JM, and Axelsen RA. Ultrastructural studies of the reaction of urate crystals with a cultured renal tubular cell line. Nephron 59: 403-408, 1991.
8. Emmerson BT, Cross M, Osborne JM, and Axelson RA. Reaction of MDCK cells to crystals of monosodium urate monohydrate and uric acid. Kidney Int 37: 36-43, 1990.
9. Ettinger B, Tang A, Citron JT, Livermore B, and Williams T. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 315: 1386-1389, 1986.
10. Finlayson B, Newman RC, and Hunter PC. The role of urate and allopurinol in stone disease: a review. In: Urolithiasis and Related Research, edited by Schwille PO, Smith LH, Robertson WG, and Vahlensieck W. New York: Plenum, 1985, p. 499-503.
11. Grases F, Costa-Bauza A, March JG, and Masarova L. Glycosaminoglycans, uric acid and calcium oxalate urolithiasis. Urol Res 19: 375-380, 1991.
12. Hess B, Nakagawa Y, and Coe FL. Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am J Physiol Renal Fluid Electrolyte Physiol 257: F99-F106, 1989.
13. Hess B, Nakagawa Y, Parks JH, and Coe FL. Molecular abnormality of Tamm-Horsfall glycoprotein in calcium oxalate nephrolithiasis. Am J Physiol Renal Fluid Electrolyte Physiol 260: F569-F578, 1991.
14. Lieske JC, Leonard R, Swift HS, and Toback FG. Adhesion of calcium oxalate monohydrate crystals to anionic sites on the surface of renal epithelial cells. Am J Physiol Renal Fluid Electrolyte Physiol 270: F192-F199, 1996.
15. Lieske JC, Leonard R, and Toback FG. Adhesion of calcium oxalate monohydrate crystals to renal epithelial cells is inhibited by specific anions. Am J Physiol Renal Fluid Electrolyte Physiol 268: F604-F612, 1995.
16. Lieske JC, Norris R, Swift H, and Toback FG. Adhesion, internalization and metabolism of calcium oxalate monohydrate crystals by renal epithelial cells. Kidney Int 52: 1291-1301, 1997.
17. Lieske JC, Norris R, and Toback FG. Adhesion of hydroxyapatite crystals to anionic sites on the surface of renal epithelial cells. Am J Physiol Renal Physiol 273: F224-F233, 1997.
18. Lieske JC, Swift HS, Martin T, Patterson B, and Toback FG. Renal epithelial cells rapidly bind and internalize calcium oxalate monohydrate crystals. Proc Natl Acad Sci USA 91: 6987-6991, 1994.
19. Lieske JC, Walsh-Reitz MM, and Toback FG. Calcium oxalate monohydrate crystals are endocytosed by renal epithelial cells and induce proliferation. Am J Physiol Renal Fluid Electrolyte Physiol 262: F622-F630, 1992.
20. Lonsdale K. Epitaxy as a growth factor in urinary calculi and gallstones. Nature 217: 56-58, 1968.
21. Mandel G and Mandel N. Crystal-crystal interactions. In: Kidney Stones: Medical and Surgical Management, edited by Coe FL, Favus MJ, Pak CYC, Parks JH, and Preminger GM. New York: Lippincott-Raven, 1996, p. 115-127.
22. Mandel NS. The structural basis of crystal-induced membranolysis. Arthritis Rheum 19: 439-445, 1976.
23. Mandel NS and Mandel GS. Urinary tract stone disease in the United States veteran population. II. Geographical analysis of variations in composition. J Urol 142: 1516-1521, 1989.
24. Nakagawa Y, Sirivongs D, Novy MB, Netzer MF, Michaels E, Vogelzang NJ, and Coe FL. Nephrocalcin: biosynthesis by human renal carcinoma cells in vitro and in vivo. Cancer Res 52: 1573-1579, 1992.
25. Pak CY and Arnold LH. Heterogeneous nucleation of calcium oxalate by seeds of monosodium urate. Proc Soc Exp Biol Med 149: 930-932, 1975.
26. Pak CY, Koenig K, Khan R, Haynes S, and Padalino P. Physicochemical action of potassium-magnesium citrate in nephrolithiasis. J Bone Miner Res 7: 281-285, 1992.
27. Parks JH and Coe FL. Urine citrate and calcium in calcium nephrolithiasis. Adv Exp Med Biol 208: 445-449, 1986.
28. Riese RJ, Kleinman JG, Wiessner JH, Mandel GS, and Mandel NS. Uric acid crystal binding to renal inner medullary collecting duct cells in primary culture. J Am Soc Nephrol 1: 187-192, 1990.
29. Ringertz H. The molecular and crystal structure of uric acid. Acta Cryst 20: 397-403, 1966.
30. Ryall RL, Hibberd CM, and Marshall VR. The effect of crystalline monosodium urate on the crystallisation of calcium oxalate in whole human urine. Urol Res 14: 63-65, 1986.
31. Shiraga H, Min W, VanDusen WJ, Clayman MD, Miner D, Terrell CH, Sherbotie JR, Foreman JW, Przysiecki C, Neilson EG, and Hoyer JR. Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sci USA 89: 426-430, 1992.
32. Tiselius HG and Larsson L. Urinary excretion of urate in patients with calcium oxalate stone disease. Urol Res 11: 279-283, 1983.
33. Unwin R, Wrong O, Cohen E, Tanner M, and Thakker R. Unraveling of the molecular mechanisms of kidney stones. Lancet 348: 1561-1565, 1996.
34. Verkoelen CF, van der Boom BG, and Romijn JC. Cell density dependent calcium oxalate crystal binding to sulphated proteins at the surface of MDCK cells (Abstract). Urolithiasis: 208-211, 1996.
35. Weissmann G and Rita GA. Molecular basis of gouty inflammation: interaction of monosodium urate monohydrate crystals with lysosomes and liposomes. Nature 240: 167-172, 1972.
36. Worcester EM, Blumenthal SS, Beshensky AM, and Lewand DL. The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin. J Bone Miner Res 7: 1029-1036, 1992.
37. Worcester EM, Nakagawa Y, Wabner CL, Kumar S, and Coe FL. Crystal adsorption and growth slowing by nephrocalcin, albumin, and Tamm-Horsfall protein. Am J Physiol Renal Fluid Electrolyte Physiol 255: F1197-F1205, 1988.
38. Zerwekh JE, Holt K, and Pak CY. Natural urinary macromolecular inhibitors: attenuation of inhibitory activity by urate salts. Kidney Int 23: 838-841, 1983.